# Accelerated Corneal Cross-linking With Different Riboflavin Solutions

> **NCT03187912** · PHASE3 · COMPLETED · sponsor: **Medical University of Vienna** · enrollment: 60 (actual)

## Conditions studied

- Keratoconus

## Interventions

- **DRUG:** Riboflavin

## Key facts

- **NCT ID:** NCT03187912
- **Lead sponsor:** Medical University of Vienna
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-09-19
- **Primary completion:** 2020-03-30
- **Final completion:** 2020-03-30
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2021-03-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03187912

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03187912, "Accelerated Corneal Cross-linking With Different Riboflavin Solutions". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT03187912. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*